AstraZeneca Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	240,738	213,845	162,287	164,292	173,826	134,436
Market Cap Growth	31.73%	31.77%	-1.22%	-5.49%	29.30%	39.84%
Enterprise Value	258,580	232,118	182,260	184,338	197,853	154,735
Last Close Price	155.22	137.90	102.46	101.53	105.24	79.54
PE Ratio	31.94	28.15	28.88	35.14	63.70	1625.31
Forward PE	20.37	18.34	14.36	17.08	18.65	18.61
PS Ratio	5.52	4.90	3.76	4.57	4.72	4.87
PB Ratio	6.65	5.91	4.97	5.34	5.65	4.63
P/FCF Ratio	27.54	24.46	20.45	23.29	24.03	37.36
P/OCF Ratio	22.23	19.75	17.13	20.23	21.35	30.53
PEG Ratio	1.68	1.54	1.17	1.47	1.29	0.95
EV/Sales Ratio	5.92	5.32	4.22	5.13	5.38	5.60
EV/EBITDA Ratio	17.86	15.85	12.99	16.51	17.35	31.27
EV/EBIT Ratio	24.91	22.35	17.65	24.34	27.05	72.32
EV/FCF Ratio	29.58	26.55	22.96	26.14	27.35	43.01
Debt / Equity Ratio	0.61	0.61	0.75	0.76	0.84	0.85
Debt / EBITDA Ratio	1.51	1.51	1.70	2.04	2.23	4.81
Debt / FCF Ratio	2.53	2.53	3.07	3.30	3.57	6.85
Net Debt / Equity Ratio	0.49	0.49	0.61	0.61	0.67	0.69
Net Debt / EBITDA Ratio	1.22	1.22	1.42	1.67	1.81	4.02
Net Debt / FCF Ratio	2.04	2.04	2.51	2.65	2.86	5.54
Asset Turnover	0.54	0.54	0.53	0.46	0.44	0.44
Inventory Turnover	1.82	1.82	1.80	1.59	1.26	1.85
Quick Ratio	0.72	0.72	0.67	0.58	0.62	0.67
Current Ratio	0.94	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	22.84%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	8.01%	8.01%	7.88%	6.10%	5.46%	2.10%
Return on Invested Capital (ROIC)	16.12%	16.66%	16.27%	13.35%	13.75%	6.00%
Return on Capital Employed (ROCE)	16.80%	16.80%	17.00%	13.70%	12.60%	3.50%
Earnings Yield	3.16%	3.55%	3.46%	2.85%	1.57%	0.06%
FCF Yield	3.63%	4.09%	4.89%	4.29%	4.16%	2.68%
Dividend Yield	1.52%	1.72%	2.42%	2.24%	2.29%	2.67%
Payout Ratio	48.62%	48.62%	65.80%	75.25%	132.72%	3442.86%
Buyback Yield / Dilution	0.06%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	1.62%	1.79%	2.35%	2.11%	-7.03%	-6.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.